CHIARUGI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.811
EU - Europa 12.636
AS - Asia 6.190
SA - Sud America 870
AF - Africa 187
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 5
Totale 35.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.480
PL - Polonia 3.879
RU - Federazione Russa 2.963
IT - Italia 2.571
SG - Singapore 1.929
CN - Cina 1.333
HK - Hong Kong 1.000
BR - Brasile 676
VN - Vietnam 660
SE - Svezia 655
IE - Irlanda 650
KR - Corea 471
DE - Germania 434
FR - Francia 308
FI - Finlandia 297
UA - Ucraina 291
GB - Regno Unito 290
CA - Canada 244
IN - India 205
BD - Bangladesh 120
AU - Australia 91
ID - Indonesia 90
NL - Olanda 81
AR - Argentina 75
TR - Turchia 72
JO - Giordania 69
ES - Italia 59
JP - Giappone 51
CH - Svizzera 50
CI - Costa d'Avorio 39
MX - Messico 39
EC - Ecuador 33
ZA - Sudafrica 31
BE - Belgio 29
IQ - Iraq 28
MA - Marocco 23
CO - Colombia 21
CL - Cile 20
NG - Nigeria 19
VE - Venezuela 18
MY - Malesia 17
PK - Pakistan 17
SC - Seychelles 17
PH - Filippine 16
EG - Egitto 15
TH - Thailandia 15
AE - Emirati Arabi Uniti 12
AT - Austria 12
AL - Albania 11
PY - Paraguay 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
DK - Danimarca 10
CR - Costa Rica 9
DZ - Algeria 9
NP - Nepal 9
PE - Perù 9
TN - Tunisia 9
JM - Giamaica 8
KE - Kenya 8
AZ - Azerbaigian 7
SN - Senegal 7
CZ - Repubblica Ceca 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
TW - Taiwan 6
BO - Bolivia 5
GR - Grecia 5
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
IR - Iran 4
NI - Nicaragua 4
RO - Romania 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BJ - Benin 3
CY - Cipro 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
MM - Myanmar 3
OM - Oman 3
PR - Porto Rico 3
AM - Armenia 2
IL - Israele 2
MD - Moldavia 2
QA - Qatar 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
Totale 35.773
Salva come PNG Salva come JPEG
Città #
Warsaw 3.874
Santa Clara 2.289
Ashburn 2.084
Fairfield 1.621
Singapore 1.398
Hong Kong 849
Woodbridge 699
Chandler 683
Dublin 650
Seattle 645
Houston 621
Cambridge 612
San Jose 553
Wilmington 505
Seoul 430
Jacksonville 416
Milan 360
Florence 352
Beijing 317
Ann Arbor 274
Altamura 241
Lawrence 234
Buffalo 216
Ho Chi Minh City 204
Princeton 188
Hefei 185
Los Angeles 178
Lauterbourg 166
Rome 156
Council Bluffs 155
Munich 154
The Dalles 147
Mcallen 145
Montréal 135
Boardman 129
Boston 127
Dallas 121
Moscow 121
Hanoi 120
Mumbai 108
Helsinki 102
New York 92
Medford 89
Melbourne 88
Dong Ket 86
San Diego 80
Shanghai 76
Naples 74
São Paulo 72
Jakarta 69
Paris 57
Kent 55
Phoenix 45
Tokyo 45
Bern 44
Turin 44
Guangzhou 41
Turku 41
Abidjan 39
Frankfurt am Main 38
Izmir 38
Bologna 37
Orem 37
Norwalk 36
Clifton 34
Palermo 33
Falls Church 30
London 30
Pune 29
Brussels 28
Redondo Beach 28
Auburn Hills 27
Barcelona 27
Bremen 27
Haiphong 27
Rio de Janeiro 27
Toronto 27
Bari 26
Verona 26
Brooklyn 25
Da Nang 23
Montreal 23
Seongnam 22
Andover 21
Dearborn 21
Figino 21
Hillsboro 21
Miano 21
Tianjin 20
Chennai 19
Frankfurt Am Main 19
Abuja 18
Venice 18
Washington 17
Brescia 16
Chicago 16
Longmont 16
San Francisco 16
Catania 15
Denver 15
Totale 24.716
Salva come PNG Salva come JPEG
Nome #
HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. 927
RUOLO DELL’INTERAZIONE TRA FIBROBLASTI STROMALI E CELLULE DI CARCINOMA PROSTATICO NELL’ACQUISIZIONE DI UN FENOTIPO METASTATICO. 810
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 360
Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. 355
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 336
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits 334
Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species. 320
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 318
The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy 311
EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase 310
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation. 308
ROLE OF STROMAL FIBROBLASTS INTERACTION WITH PROSTATIC CANCER CELLS IN ACHIEVEMENT OF METASTATIC PHENOTYPE. 303
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 299
The effects of CA IX catalysis products within tumor microenvironment 298
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 291
Role of stromal fibroblasts interaction with prostatic cancer cells in achievement of metastatic phenotype. 290
"β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells, 289
Globular adiponectin activates motility and regenerative traits of muscle satellite cells. 287
Redox regulation of ephrin/integrin cross-talk 283
Redox Regulation of Nonmuscle Myosin Heavy Chain during Integrin Engagement. 283
Rac and Rho GTPases in cancer cell motility control. 282
Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. 278
In vivo inactivation of phosphotyrosine protein phosphatases by nitric oxide. 276
QUANTITATIVE ANALYSIS OF LACTOYLGLUTATHIONE: A NEW 2D-HPLC-MS/MS APPROACH WITHOUT ION-PAIR AGENTS 273
Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition 273
The role of Cys-17 in the pyridoxal 5'-phosphate inhibition of the bovine liver low M(r) phosphotyrosine protein phosphatase. 272
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 267
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 267
Escaping from, moving towards, following a path, squeezing through: lots of opportunities for moving cells. 265
Reactive oxygen species: friends and foes of signal transduction. 264
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib 261
Anoikis: an emerging hallmark in health and diseases. 254
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 253
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like trait 252
Cancer stemness and progression: Mitochondria on the stage 247
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression. 241
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. 240
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 238
Aspartic-129 is an essential residue in the catalytic mechanism of the low M(r) phosphotyrosine protein phosphatase 236
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) 235
β3-adrenoreceptor and tumor microenvironment: a new hub 233
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 232
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 232
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 228
Lactate modulates CD4 + T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis 221
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. 214
Stromal-induced mitochondrial re-education: Impact on epithelial-to-mesenchymal transition and cancer aggressiveness. 214
Multiwalled carbon nanotubes for drug delivery: Efficiency related to length and incubation time 213
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. 213
The ”click-on-tube” approach for the production of efficient drug carriers based on oxidize multiwalled carbon nanotubes 213
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 213
Cloning and expression of the cDNA coding for the erythrocyte isoenzyme of human acylphosphatase. 212
Anoikis molecular pathways and its role in cancer progression. 211
Chronic Resveratrol Treatment Ameliorates Cell Adhesion and Mitigates the Inflammatory Phenotype in Senescent Human Fibroblasts 210
A novel redox-based switch: LMW-PTP oxidation enhances Grb2 binding and leads to ERK activation. 209
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 208
Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression 204
β3-adrenoceptor as a potential immuno-suppressor agent in melanoma 204
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 204
Characterization of a novel nucleolytic activity of acylphosphatases 200
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style 200
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 199
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells 198
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells. 198
Down-regulation of platelet-derived growth factor receptor signaling during myogenesis. 197
Conjugation of a GM3 lactone mimetic on carbon nanotubes enhances the related inhibition of melanoma-associated metastatic events 197
Anchorage-dependent cell growth: tyrosine kinases and phosphatases meet redox regulation. 196
Microenvironment and tumor cell plasticity: An easy way out. 196
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer 194
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis 193
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. 193
Anoikis: A necessary death program for anchorage-dependent cells. 193
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 192
An in vitro molecular study of Nicotiana tabacum L. genome in the presence or absence of the herbicide atrazine. 191
Acylphosphatase is involved in differentiation of K562 cells 191
22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis. 191
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling 190
Senescent stroma promotes prostate cancer progression: The role of miR-210 190
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. 189
Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. 189
INSULIN INHIBITS PLATELET-DERIVED GROWTH FACTOR-INDUCED CELL PROLIFERATION 189
Differential role of four cysteines on the activity of a low Mr phosphotyrosine protein phosphatase 188
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. 185
Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. 185
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 182
Lactate: A Metabolic Driver in the Tumour Landscape 181
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. 180
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. 179
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. 179
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 178
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 178
LMW-PTP is a positive regulator of tumor onset and growth 178
Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity 176
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression 176
Preferential accumulation of muscle type acylphosphatase in the nucleus during differentiation 175
Differential migration of acylphosphatase isoenzymes from cytoplasm to nucleus during apoptotic cell death. 175
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. 173
Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy 173
Low molecular weight protein-tyrosine phosphatase controls the rate and the strength of NIH-3T3 cells adhesion through its phosphorylation on tyrosine 131 or 132 172
Angiopoietin like 7, a novel pro-angiogenetic factor over-expressed in cancer 171
Totale 24.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.437 56 176 111 44 60 58 73 90 70 82 249 368
2022/20233.323 306 655 161 248 245 574 385 192 360 20 93 84
2023/20241.347 46 133 208 83 85 191 61 315 35 50 77 63
2024/20257.760 273 850 485 1.281 2.074 854 112 582 406 222 342 279
2025/202610.075 1.055 1.204 697 820 1.234 389 1.267 468 647 650 340 1.304
2026/2027173 173 0 0 0 0 0 0 0 0 0 0 0
Totale 36.085